)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Drug regulator alleges irregularities in reporting adverse events and conflict-of-interest disclosures by the unit's ethics committee during human clinical trials
Experts flag coordination gaps as Centre bets on transit-led satellite hubs
The retailer's India arm has leased 8.3 lakh sq ft at Embassy Manyata Business Park, reinforcing Bengaluru's position as the leading hub for GCC-led office demand
Developer launches Rs 1,100-crore Tulip Melrose project on Southern Peripheral Road as part of a larger luxury housing expansion plan
The removal of cough syrups from Schedule K could make access more prescription-dependent in rural India, potentially shifting some demand towards Ayush products
The acquisition adds to a series of high-value transactions at DLF's super-luxury Gurugram project, where prices have risen sharply since launch
The state regulator has directed hospitals and doctors to provide prescriptions directly to patients and allow them to buy medicines from any licensed pharmacy
The company has launched a generic version of Pfizer's Bosulif for chronic myeloid leukaemia and secured 180 days of exclusivity for the 400 mg strength
NPPA raises ceiling prices of key cancer drugs and select vaccines to address supply shortages and ensure continued availability of essential medicines
Developers brace for up to year-long project delays as the prolonged West Asia conflict raises costs, disrupts supplies and worsens labour shortages
Housing demand remains resilient and project financing is better than in previous cycles, says Anarock
Clears way for higher rates for Cisplatin and Carboplatin amid supply crunch
Vietnamese mobility firm expands workspace footprint as it scales its all-electric taxi service, with plans to add more facilities across the Delhi-NCR region
Drugmaker plans to submit orforglipron to USFDA for Type 2 diabetes approval by end of second quarter
Group launches full-stack smart co-working platform and plans to add 30-35 centres across 10 cities, targeting 50,000 seats nationwide
India's pharma sector remains resilient despite West Asia disruptions, as the government advances biopharma, R&D and bulk drug manufacturing initiatives
India plans a new support scheme for bulk drugs focused on R&D and capacity creation, while ruling out a broad medicine price hike despite rising input costs
The lease includes a 15 per cent rent escalation every three years, the documents registered in April 2026 showed
Southern states largely see stable or marginally higher fertility levels, while northern and northeastern states record declines, indicating demographic convergence
Regulator seeks state-wise enforcement data as EU, US and Japan reject consignments linked to over 40 farms